Saturday, January 28, 2023
  • Login
CEO North America
  • Home
  • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
    • Environment
  • Opinion
  • News
  • Multimedia
No Result
View All Result
  • Home
  • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
    • Environment
  • Opinion
  • News
  • Multimedia
No Result
View All Result
CEO North America
No Result
View All Result

Moderna sues Pfizer/BioNTech over Covid vaccine technology

in News
Moderna sues pfizer/biontech over covid vaccine technology
Share on FacebookShare on Twitter

Moderna is suing Pfizer and BioNTech for patent infringement in the development of the first U.S. Covid-19 vaccine approved, the company announced Friday.

The Cambridge, Massachusetts firm claims partners Pfizer and BioNTech, without permission, copied mRNA technology that Moderna had patented between 2010 and 2016, well before Covid-19 emerged late 2019.

“We are filing these lawsuits to protect the innovative mRNA technology platform that we pioneered, invested billions of dollars in creating, and patented during the decade preceding the Covid-19 pandemic,” Moderna CEO Stephane Bancel said in the statement.

Moderna had been an innovator in the messenger RNA (mRNA) vaccine technology, which shortens approval processes to months, instead of the years it took to be completed.

The lawsuit was filed in U.S. District Court in Massachusetts and the Regional Court of Dusseldorf in Germany.

The U.S. Food and Drug Administration granted emergency use authorization for the vaccine to both Pfizer/BioNTech and Moderna in consecutive weeks in December 2020.

New York based Pfizer and Mainz, Germany based BioNTech are already facing multiple lawsuits from other companies who say the partnership’s vaccine infringes on their patents.

Moderna has also been sued for patent infringement in the U.S. and has an ongoing dispute with the U.S. National Institutes of Health over rights to mRNA technology.

Tags: BioNTechCOVID vaccineFDAModernaPfizer

Related Posts

Ford recalls 462,000 vehicles for rear camera display failure
News

Ford recalls 462,000 vehicles for rear camera display failure

Us inflation and consumer spending fall for 2  straight months
News

US inflation and consumer spending fall for 2 straight months

Intel’s ‘historic collapse’ triggers selloff in chip stocks
News

Intel’s ‘historic collapse’ triggers selloff in chip stocks

Morgan stanley penalizes employees for whatsapp breaches
News

Morgan Stanley penalizes employees for WhatsApp breaches

Fewer americans file for jobless claims last week
News

Fewer Americans file for jobless claims last week

Boeing to be arraigned in court over two max jet crashes
News

Boeing to be arraigned in court over two Max jet crashes

Ad spending on twitter falls more than 70% in dec
News

Ad spending on Twitter falls more than 70% in Dec

Bank of canada raises rates, signals pause
News

Bank of Canada raises rates, signals pause

Microsoft cloud outage impacts users worldwide
News

Microsoft cloud outage impacts users worldwide

Walmart to raise its minimum wage for u. S. Hourly workers to $14
News

Walmart to raise its minimum wage for U.S. hourly workers to $14

No Result
View All Result

Recent Posts

  • Ford recalls 462,000 vehicles for rear camera display failure
  • US inflation and consumer spending fall for 2 straight months
  • Zoom fatigue finally revives travel for in-person company meetings
  • Fast food fans may face liver damage
  • Food delivery wars: Duke professor says there’s a better way

Recent Comments

    Archives

    Categories

    • Art & Culture
    • Business
    • CEO Interviews
    • CEO Life
    • Editor´s Choice
    • Entrepreneur
    • Environment
    • Food
    • Health
    • Highlights
    • Industry
    • Innovation
    • Issues
    • Management & Leadership
    • Multimedia
    • News
    • Opinion
    • PrimeZone
    • Printed Version
    • Travel
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    • CONTACT
    • GENERAL ENQUIRIES
    • ADVERTISING
    • MEDIA KIT
    • DIRECTORY
    • TERMS AND CONDITIONS

    Editorials – stuart.james@ceo-na.com

    Editor-In-Chief – caroline.sposto@ceo-na.com

    Editorials – editorials@ceo-na.com

    Advertising – media@ceo-na.com

    NEW YORK

    110 Wall St.,
    3rd Floor
    New York, NY.
    10005
    USA
    +1 212 432 5800

     

    MEXICO CITY

    Paseo de la Reforma 296,
    Floor 38
    Mexico City
    06600
    MEXICO

    • CONTACT
    • GENERAL ENQUIRIES
    • ADVERTISING
    • MEDIA KIT
    • DIRECTORY
    • TERMS AND CONDITIONS

    Editorials –
    stuart.james@ceo-na.com

    Editor-In-Chief –

    caroline.sposto@ceo-na.com

    Editorials – editorials@ceo-na.com

    Advertising –
    media@ceo-na.com

    NEW YORK

    110 Wall St.,
    3rd Floor
    New York, NY.
    10005
    USA
    +1 212 432 5800

    MEXICO CITY

    Paseo de la Reforma 296,
    Floor 38
    Mexico City
    06600
    MEXICO

    CEO North America © 2022 - Sitemap

    No Result
    View All Result
    • Home
    • Business
      • Entrepreneur
      • Industry
      • Innovation
      • Management & Leadership
    • CEO Interviews
    • CEO Life
      • Art & Culture
      • Food
      • Health
      • Travel
      • Environment
    • Opinion
    • News
    • Multimedia

    © 2023 JNews - Premium WordPress news & magazine theme by Jegtheme.

    Welcome Back!

    Login to your account below

    Forgotten Password?

    Retrieve your password

    Please enter your username or email address to reset your password.

    Log In